ALIQOPA (Bayer HealthCare Pharmaceuticals Inc.)
Welcome to the PulseAid listing for the ALIQOPA drug offered from Bayer HealthCare Pharmaceuticals Inc.. This Kinase Inhibitor [EPC],Kinase Inhibitors [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Bayer HealthCare Pharmaceuticals Inc. |
| NON-PROPRIETARY NAME: | copanlisib |
| SUBSTANCE NAME: | COPANLISIB |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Kinase Inhibitor [EPC],Kinase Inhibitors [MoA] |
| ROUTE: | INTRAVENOUS |
| DOSAGE FORM: | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
| MARKETING CATEGORY NAME: | NDA |
| START MARKETING DATE: | 2017-09-14 |
| END MARKETING DATE: | 0000-00-00 |
ALIQOPA HUMAN PRESCRIPTION DRUG Details:
| Item Description | ALIQOPA from Bayer HealthCare Pharmaceuticals Inc. |
| LABELER NAME: | Bayer HealthCare Pharmaceuticals Inc. |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 15(mg/mL) |
| START MARKETING DATE: | 2017-09-14 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 50419-385_f372a5e6-a0f0-44e8-8d79-f5a616ea207b |
| PRODUCT NDC: | 50419-385 |
| APPLICATION NUMBER: | NDA209936 |
Other COPANLISIB Pharmaceutical Manufacturers / Labelers:
